Latest Issue

Volume 3 Issue 3

Paper of the Month

Pathophysiology of multiple sclerosis and the place of teriflunomide.

Gold R, Wolinsky JS.
St Josef-Hospital, University of Bochum, Bochum, Germany.
Acta Neurol Scand 2011;124:75–84.
Editor’s note: Multiple sclerosis (MS) is an autoimmune, neuroinflammatory disease mediated by autoreactive immune cells that become activated in the periphery and then cross the blood–brain barrier and cause inflammatory lesions in the central nervous system (CNS).
» Read an expert review of this paper

Webcast

Rehabilitation in multiple sclerosis
Prof Alan Thompson (Director, UCL Institute of Neurology, London, UK) discusses rehabilitation for people with multiple sclerosis.

Latest news

  • Home
  • Home
  • Home
  • Home
  • Home
  • Home

READER SURVEY

SUBMIT AN ARTICLE

OTHER REMEDICA JOURNALS

COMPASS PUBMED SEARCH

Enter your search terms below to search pubmed for articles